2025-12-06 - Analysis Report
Okay, let's break down the provided information on Procter & Gamble (PG) and analyze its current standing.

**0) Report Summary:**

**Simple Numbers First:**

*   **Cumulative Return (PG):** 28.10%
*   **Cumulative Return (VOO):** 100.58%
*   **Divergence (PG vs VOO):** -72.3%
*   **Last Price:** \$146.71
*   **Last Market Price:** \$143.46
*   **5-day SMA:** 147.05
*   **20-day SMA:** 147.31
*   **60-day SMA:** 150.67
*   **RSI:** 46.07
*   **PPO:** 0.02
*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **Expected Return:** 52.9%
*   **Analyst Consensus:** Buy (Mean = 2.00)
*   **Target Price (avg):** \$169.05

**Simple Analysis:**

*   PG has significantly underperformed the S&P 500 (VOO) over the given period.
*   Recent price action shows PG is trading below its 5-day, 20-day, and 60-day moving averages, suggesting a downtrend.
*   The RSI is neutral, indicating neither overbought nor oversold conditions.
*   The Market Risk Indicator suggests a medium investment recommendation.
*   Analysts have a "Buy" consensus with a target price considerably higher than the current price.
*   Recent news headlines are largely negative, highlighting investor concerns and a 2-year low stock price.

**1) Return Rate Comparison (PG vs VOO):**

*   **Ticker:** PG
*   **Company Name:** Procter & Gamble Co. (A multinational consumer goods corporation focused on providing branded consumer packaged goods.)
*   **Cumulative Return (PG):** 28.10%
*   **Cumulative Return (VOO):** 100.58%
*   **Divergence:** -72.3%
*   **Relative Divergence:** 1.7

**Analysis:** PG has significantly underperformed the S&P 500 (VOO) over the period reflected in the cumulative return data. The large negative divergence indicates a substantial difference in performance. The Relative Divergence of 1.7 suggests it is near the bottom of its historical fluctuation range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | 21.0%   | 7.9%  | -8.0%   | 0.0   | 210.2  |
| 2016-2018  | 9.0%    | 67.3% | -6.0%   | 0.1   | 210.3  |
| 2017-2019  | 24.0%   | 70.4% | 2.0%    | 0.3   | 285.8  |
| 2018-2020  | 27.0%   | 78.8% | 4.0%    | 0.4   | 318.4  |
| 2019-2021  | 41.0%   | 78.8% | -5.0%   | 0.5   | 374.3  |
| 2020-2022  | 13.0%   | 79.4% | 13.0%   | 0.6   | 346.8  |
| 2021-2023  | 26.0%   | 79.4% | 24.0%   | 0.4   | 335.3  |
| 2022-2024  | 9.0%    | 79.4% | -12.0%  | 0.4   | 383.6  |
| 2023-2025  | -16.0%  | 80.1% | -81.0%  | 0.2   | 335.7  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** Varies significantly, with a recent decline in 2023-2025.
*   **MDD (Maximum Drawdown):** Relatively high, particularly in recent periods, indicating potential volatility.
*   **Alpha:** Fluctuates, with strong negative alpha in the 2023-2025 period, indicating underperformance relative to its benchmark.
*   **Beta:** Generally low, suggesting lower sensitivity to market movements compared to the overall market.
*   **Cap(B) (Capitalization in Billions):** Shows overall growth in market capitalization over the years, though it has fluctuated.

**2) Recent Stock Price Fluctuations:**

*   **Close:** 146.71
*   **Last Market:** price: 143.455, previousClose: 145.36, change: -1.31
*   **5-day SMA:** 147.05
*   **20-day SMA:** 147.31
*   **60-day SMA:** 150.67

**Analysis:** The current market price is slightly down compared to the previous close and below all three SMAs. This suggests a short-term downtrend.

**3) RSI, PPO, and Divergence Analysis:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 46.07
*   **PPO:** 0.02
*   **Hybrid Signal:** cash\_0% Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -9.2 (-): Short-term decline
*   **Expected Return (%):** 52.9% (Long-term expectation)

**Analysis:**

*   The MRI suggests a medium level of risk for investment.
*   The RSI is neutral, not indicating overbought or oversold conditions.
*   The negative change in relative divergence suggests a recent underperformance compared to the benchmark.
*   Despite the recent struggles, the expected return is high, suggesting potential for future growth from this point onward, based on the algorithm's assessment.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **[2025-12-02] Why Procter & Gamble Stock Hit a 2-Year Low on Tuesday:** Highlights negative price action and potential investor concerns.
*   **[2025-12-02] Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know:** Suggests heightened investor interest, potentially due to the price decline.
*   **[2025-12-05] Procter & Gamble Stock: A Cash Cow That Is Still A Sell (NYSE:PG):**  Suggests that the stock, despite being a stable company, may not be a good investment at the current time.
*   **[2025-11-18] Why Procter & Gamble Stock (PG) is Primed for a Wake-Up Call:** Hints at potential for future positive movement, but the timing is uncertain.
*   **[2025-12-02] Procter & Gamble Stock Drops. Its CFO Says Consumers Are Nervous.:**  Indicates concerns about consumer behavior and potential impact on the company.
*   **[2025-12-02] Procter & Gamble (PG) Stock: Shares Hit 52-Week Low as CFO Warns of Volatile U.S. Market:**  Further emphasizes negative price action and market volatility.

**Analysis:** Recent news sentiment appears primarily negative, driven by price declines, concerns about consumer spending, and warnings about the stock's current attractiveness as an investment.

**4-2) Analyst Opinions:**

*   **Analyst Consensus:** Buy (Mean = 2.00)
*   **Target Price (avg/high/low):** 169.05 / 186.00 / 148.00

**Analysis:** Despite the negative news flow, analysts, on average, maintain a "Buy" rating with a target price significantly above the current market price, indicating potential upside.

**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-10-24 | 2     | 22.39 B$ |
| 2025-04-24 | 1.58  | 19.78 B$ |
| 2025-01-22 | 1.94  | 21.88 B$ |
| 2024-10-18 | 1.65  | 21.74 B$ |
| 2025-10-24 | 1.65  | 21.74 B$ |

**Analysis:** Revenue and EPS (Earnings Per Share) have fluctuated, with the most recent quarter showing strong EPS but with a typo (duplicated row). It's difficult to discern a clear trend from this limited dataset.

**6) Financial Information:**

Revenue and Profitability:

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-09-30 | $22.39B    | 51.37%        |
| 2025-06-30 | $20.89B    | 49.11%        |
| 2025-03-31 | $19.78B    | 50.98%        |
| 2024-12-31 | $21.88B    | 52.39%        |
| 2024-09-30 | $21.74B    | 52.06%        |

Capital and Profitability:

| Quarter    | Equity     | ROE     |
|------------|------------|---------|
| 2025-09-30 | $53.27B    | 8.92%   |
| 2025-06-30 | $52.01B    | 6.95%   |
| 2025-03-31 | $52.27B    | 7.21%   |
| 2024-12-31 | $51.17B    | 9.05%   |
| 2024-09-30 | $51.84B    | 7.64%   |

**Analysis:**

*   Revenue has fluctuated but remains high.
*   Profit margins are consistently strong, indicating good operational efficiency.
*   Equity is trending upwards.
*   ROE (Return on Equity) fluctuates but remains generally healthy.

**7) Comprehensive Analysis (Summary):**

Procter & Gamble (PG) is a large, stable consumer goods company with a history of generating strong revenue and profit margins. However, it has significantly underperformed the S&P 500 recently, and its stock price has declined.  Recent news sentiment is primarily negative, driven by these factors and concerns about the broader economic environment.

While technical indicators suggest a short-term downtrend, analysts maintain a "Buy" rating, indicating potential upside based on the company's fundamentals and future expectations. The company's relatively low beta suggests it might be less volatile than the overall market.

**In summary:**

*   **Short-Term:** Caution is warranted due to negative price action and negative news flow.
*   **Long-Term:** P&G fundamentals remain relatively sound, and analysts anticipate positive returns. The significantly higher target price compared to the recent stock price drop supports this.

The investment decision ultimately depends on individual risk tolerance and investment horizon. While the current situation presents challenges, P&G's historical stability and analyst outlook suggest potential for future growth.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.